Agency
Healtheast ST Josephs Hospital
Healtheast ST Josephs Hospital was paid $4.35M by Medicaid between Jan 2018 and Jun 2022, across 79 billing codes. Its largest line is 99285, emergency room visit (most serious) — 33% of everything it billed.
33Billing provider infoHEALTHEAST ST JOSEPHS HOSPITAL
SAINT PAUL, MN 55102
SAINT PAUL, MN 55102
33aNPI1134186273assigned 05/01/2006
33bProvider typeCase Management Agency
28Total paid$4.35M
24GClaims130,524
24DCodes billed79
24AFirst – last monthJan 2018 – Jun 2022
Compared with peers
Next to other Case Management Agency providers in Minnesota
Rank by total paid#46 of 134
Median peer was paid$1.47M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,971 | $882K | |
| 2019 | 35,379 | $1.64M | |
| 2020 | 26,528 | $1.22M | |
| 2021 | 21,575 | $470K | |
| 2022 | 7,071 | $136K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 33% | 5,964 | 5,100 | $1.42M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19% | 20,315 | 8,749 | $821K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 3,647 | 3,173 | $445K |
| H2035 | Alcohol and/or other drug treatment program, per hour | 8.8% | 4,607 | 729 | $381K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.1% | 4,402 | 3,526 | $308K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.2% | 1,812 | 1,529 | $183K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 4.2% | 1,770 | 943 | $181K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.7% | 10,148 | 4,314 | $119K |
| 80053 | Comprehensive metabolic panel | 1.7% | 3,132 | 2,666 | $75K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 3,399 | 2,617 | $59K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 1,088 | 870 | $57K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 3,762 | 2,450 | $50K |
67 more codes
| 36415 | Collection of venous blood by venipuncture | 1.1% | 18,928 | $50K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 11,834 | $33K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 741 | $33K |
| H0001 | Alcohol and/or drug assessment | <1% | 250 | $31K |
| 90837 | Psychotherapy session, about an hour | <1% | 330 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,965 | $21K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 663 | $9K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 15,904 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 303 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,193 | $5K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 58 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 173 | $3K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 25 | $3K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 19 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 170 | $2K |
| 84484 | <1% | 891 | $2K | |
| 85027 | <1% | 695 | $2K | |
| 86481 | <1% | 17 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,842 | $1K |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 45 | $1K |
| 86682 | <1% | 82 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 194 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 104 | $1K |
| 86480 | <1% | 12 | $917.40 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29 | $695.85 |
| 86803 | <1% | 43 | $644.16 | |
| 81001 | <1% | 433 | $625.27 | |
| 86708 | <1% | 44 | $586.72 | |
| 86787 | <1% | 41 | $567.26 | |
| 86704 | <1% | 43 | $557.43 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 578 | $441.13 |
| 87340 | <1% | 39 | $415.38 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 112 | $399.89 |
| 83970 | <1% | 15 | $360.88 | |
| 80061 | Lipid panel | <1% | 95 | $339.80 |
| 82607 | <1% | 70 | $332.66 | |
| 86706 | <1% | 29 | $312.63 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 219 | $219.78 |
| 71045 | Radiologic examination, chest; single view | <1% | 21 | $188.68 |
| 83735 | <1% | 271 | $144.80 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 29 | $125.69 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 299 | $112.50 |
| 85018 | <1% | 98 | $108.51 | |
| C2617 | Stent, non-coronary, temporary, without delivery system | <1% | 29 | $85.84 |
| 82565 | <1% | 39 | $63.47 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 165 | $57.00 |
| 85610 | <1% | 172 | $49.10 | |
| 81003 | <1% | 462 | $46.26 | |
| 82365 | <1% | 15 | $38.51 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 204 | $29.76 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 61 | $26.35 |
| 82248 | <1% | 68 | $16.45 | |
| 84703 | <1% | 28 | $15.36 | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 43 | $13.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 19 | $7.37 |
| J2704 | Injection, propofol, 10 mg | <1% | 52 | $4.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 28 | $3.60 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 16 | $2.62 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 16 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 134 | $0.00 |
| A9270 | Non-covered item or service | 0% | 1,679 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 57 | $0.00 |
| J3490 | Unclassified drugs | 0% | 26 | $0.00 |
| 83690 | 0% | 162 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 12 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 33 | $0.00 |
| C1769 | Guide wire | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCOY, ROBERT (VP REVENUE MANAGEMENT)
| Provider | Location | Paid |
|---|---|---|
| Fairview Express Care | Minneapolis, MN | $5.03M |
| Home Care Technologies LTD. | Chicago, IL | $888K |
| Fairview Express Care | Forest Lake, MN | $686K |
| Fairview Express Care | Burnsville, MN | $121K |
| Dakota Chiropractic & Wellness Center Prof LLC | Sioux Falls, SD | $54K |
| Fairview Express Care | Eagan, MN | $19K |
| Robert M. Mccoy, MD, INC | Fairmont, WV | $7K |
| Fairview Clinics | Rush City, MN | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.